Nat Clin Pract Cardiovasc Med. 2009 Mar;6(3):168-9. Epub 2009 Jan 20.

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?

Source

University of Oxford Diabetes Trials Unit, Oxford, UK.

Abstract

The POPADAD (Prevention Of Progression of Arterial Disease And Diabetes) study did not show a benefit for low-dose aspirin therapy or administration of antioxidants for the primary prevention of cardiovascular disease events in individuals with diabetes and asymptomatic peripheral arterial disease. Although low-dose aspirin continues to be recommended in international guidelines, no convincing trial-based evidence exists that supports its routine use for primary prevention of cardiovascular disease in people with diabetes. This paradox is unhelpful and the guidelines should be relaxed until definitive evidence becomes available.

PMID:: 19153560; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

ACETYLSALICYLIC ACID - HSDB

Supplemental Content

Save items

Related citations in PubMed

The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. [BMJ. 2008]
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.
Belch J, MacCuish A, Campbell I, Cobbe S, Taylor R, Prescott R, Lee R, Bancroft J, MacEwan S, Shepherd J, et al. BMJ. 2008 Oct 16; 337:a1840. Epub 2008 Oct 16.
Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. [Diabetes Care. 2003]
Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.
Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A, PPP Collaborative Group. Diabetes Care. 2003 Dec; 26(12):3264-72.
Review Aspirin for primary prevention of cardiovascular events in people with diabetes. [J Am Coll Cardiol. 2010]
Review Aspirin for primary prevention of cardiovascular events in people with diabetes.
Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS, et al. J Am Coll Cardiol. 2010 Jun 22; 55(25):2878-86.
Review [Low-dose aspirin in patients with diabete melitus: risks and benefits regarding macro and microvascular complications]. [Arq Bras Endocrinol Metabol. 2...]
Review [Low-dose aspirin in patients with diabete melitus: risks and benefits regarding macro and microvascular complications].
Camargo EG, Gross JL, Weinert LS, Lavinsky J, Silveiro SP. Arq Bras Endocrinol Metabol. 2007 Apr; 51(3):457-65.
Review Aspirin dose for prevention of cardiovascular disease in diabetics. [Ann Pharmacother. 2003]
Review Aspirin dose for prevention of cardiovascular disease in diabetics.
Nowak SN, Jaber LA. Ann Pharmacother. 2003 Jan; 37(1):116-21.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Primary prevention of cardiovascular events in diabetes: is there a role for asp...
Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
Nat Clin Pract Cardiovasc Med. 2009 Mar ;6(3):168-9. Epub 2009 Jan 20 .

PubMed
The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptide...
The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9.
Acta Crystallogr D Biol Crystallogr. 2009 Jan ;65(Pt 1):58-66. Epub 2008 Dec 18 .

PubMed
Personalized genetic prediction: too limited, too expensive, or too soon?
Personalized genetic prediction: too limited, too expensive, or too soon?
Ann Intern Med. 2009 Jan 20 ;150(2):139-41.

PubMed
Narrative review: effect of bariatric surgery on type 2 diabetes mellitus.
Narrative review: effect of bariatric surgery on type 2 diabetes mellitus.
Ann Intern Med. 2009 Jan 20 ;150(2):94-103.

PubMed
Cost-effectiveness of using pharmacogenetic information in warfarin dosing for p...
Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation.
Ann Intern Med. 2009 Jan 20 ;150(2):73-83.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: